OncoTargets and Therapy
Volume 3, 2010 - Issue
Open access
74
Views
2
CrossRef citations to date
0
Altmetric
Review
Temsirolimus in the treatment of relapsed or refractory mantle cell lymphoma
Nousheen Samad1 Division of Pharmacy, Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
& Anas Younes2 Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
Pages 167-178
|
Published online: 06 Sep 2010
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.